| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/17/2003 | EP1343520A2 New therapeutic uses of smr1 peptides |
| 09/17/2003 | EP1343519A2 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 09/17/2003 | EP1343516A2 Analogues of thiocoraline and be-22179 |
| 09/17/2003 | EP1343513A1 Compositions containing an active fraction isolated from scutellariae barbatae and methods of use |
| 09/17/2003 | EP1343511A1 Shark meat extract |
| 09/17/2003 | EP1343506A1 Pharmaceutical formulation containing pyrazolo 4,3-d]pyrimidines and antithrombotic agents, calcium-antagonists, prostaglandins or prostaglandin derivatives |
| 09/17/2003 | EP1343505A1 Cxcr3 antagonists |
| 09/17/2003 | EP1343496A1 Anticancer agent comprising mycolactone |
| 09/17/2003 | EP1343488A1 Treatment of statin side effects |
| 09/17/2003 | EP1343487A2 Methods and compositions to treat conditions associated with neovascularization |
| 09/17/2003 | EP1343485A2 Lipid-based nitric oxide donors |
| 09/17/2003 | EP1343477A2 Treatment of inoperable tumors by stereotactic injection of microspheres |
| 09/17/2003 | EP1343476A2 Preparation of large liposomes by infusion into peg |
| 09/17/2003 | EP1343434A1 Methods for contemporaneous administration of levamisole and 5-fluorouracil |
| 09/17/2003 | EP1207875B1 Pharmaceutically stable oxaliplatinum preparation for parenteral administration |
| 09/17/2003 | EP1183241B1 Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 09/17/2003 | EP1133471B1 Hydrazine derivatives |
| 09/17/2003 | EP1123296B1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION |
| 09/17/2003 | EP1091763B1 Antiviral and antiretroviral radioimmunomedicaments based on alpha-emitters and beta-emitters |
| 09/17/2003 | EP1091734B1 Method for reducing the damaging effects of radiation therapy on animal skin and mucosa |
| 09/17/2003 | EP1060242A4 Purified populations of stem cells |
| 09/17/2003 | EP1042327B1 A process for the reduction of oxiranyl epothilones to olefinic epothilones |
| 09/17/2003 | EP1027359B9 Monocyclic l-nucleosides, analogs and uses thereof |
| 09/17/2003 | EP1009755B1 Steroid sulfatase inhibitors and methods for making and using the same |
| 09/17/2003 | EP0972782B1 Monoclonal antibody which recognizes the oligosaccharide n-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it |
| 09/17/2003 | EP0909184B1 Targeted drug delivery using sulfonamide derivatives |
| 09/17/2003 | EP0891329B1 Peptidyl compounds having mmp and tnf inhibitory activity |
| 09/17/2003 | EP0842428B1 Process for producing gm2 specific antibodies |
| 09/17/2003 | EP0804439B1 Beta, beta '-dihydroxy meso-substituted chlorins, isobacteriochlorins, bacteriochlorins, and methods for making the same from beta ,beta '-unsubstituted tetrapyrrolic macrocycles |
| 09/17/2003 | EP0754682B9 Aminostilbazole derivative and medicine |
| 09/17/2003 | EP0724647A4 Nucleic acid ligands and improved methods for producing the same |
| 09/17/2003 | EP0702683B1 06-substituted guanine derivatives, a process for their preparation and their use in treating tumour cells |
| 09/17/2003 | EP0669988B1 Angiogenesis inhibitory antibodies |
| 09/17/2003 | EP0668762B1 Isobutenyl-substituted taxanes and their pharmaceutical compositions |
| 09/17/2003 | CN1443243A 修饰的病毒 Modified viruses |
| 09/17/2003 | CN1443241A Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, proteins encoded, and uses thereof |
| 09/17/2003 | CN1443239A Compositions and methods for therapy and diagnosis of breast cancer |
| 09/17/2003 | CN1443238A Tumor-specific promoters |
| 09/17/2003 | CN1443199A Antibodies to human MCP-1 |
| 09/17/2003 | CN1443198A Ghrelin拮抗剂 Ghrelin Antagonist |
| 09/17/2003 | CN1443197A Acid-modified arabinogalactan protein composition |
| 09/17/2003 | CN1443195A LHRH-antagonists, production and use thereof as medicament |
| 09/17/2003 | CN1443190A Matrix metalloproteinase inhibitors |
| 09/17/2003 | CN1443189A Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same |
| 09/17/2003 | CN1443187A Fused cyclic compounds as modulators of nuclear hormone receptor function |
| 09/17/2003 | CN1443184A 嘧啶衍生物 Pyrimidine derivatives |
| 09/17/2003 | CN1443179A Aniline derivatives |
| 09/17/2003 | CN1443178A (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphtyl] -4-morpholibenzamide |
| 09/17/2003 | CN1443173A Substituted imidazoles as TAFI a inhibitors |
| 09/17/2003 | CN1443172A Novel heteroaryl derivatives and use thereof as pharmaceuticals |
| 09/17/2003 | CN1443171A Novel heteroaryl derivatives and use thereof as pharmaceuticals |
| 09/17/2003 | CN1443164A Pyrrolidine derivatives as metalloprotease inhibitors |
| 09/17/2003 | CN1443163A Pyrrolidine-2-carboxylic acid hydrozide derivatives for use as metalloprotease inhibitors |
| 09/17/2003 | CN1443160A N-substituted-1-amino-1,1-dialkyl carboxylic acid derivatives |
| 09/17/2003 | CN1443079A Polymeric conjugates of antitumor agents |
| 09/17/2003 | CN1443077A CD40-binding APC-activating molecules |
| 09/17/2003 | CN1443070A Apoptosis inhibiting composition comprising 15-keto-prostaglandin or derivative thereof |
| 09/17/2003 | CN1443065A Pharmaceutical composition improved in peroral absorbability |
| 09/17/2003 | CN1443064A Administration of thiol-based chemoprotectant compound |
| 09/17/2003 | CN1442430A AsLc-IFN fusion protein and its preparation |
| 09/17/2003 | CN1442419A Di (N-chlorolactamic acid) potassium platinate, its preparation method and its application |
| 09/17/2003 | CN1442413A Method of extracting medical taxadol and its derivative using regenerable resources |
| 09/17/2003 | CN1442201A Compound containing osteoclast formation inhibiting factor and polysaccharide |
| 09/17/2003 | CN1442188A Cat ginseng injection liquid and its preparation method and use |
| 09/17/2003 | CN1442185A Medicine for treating uterus myoma disease and its preparation method |
| 09/17/2003 | CN1442180A Medicine used for treating esophageal cancer and gastric ancer and its preparation method |
| 09/17/2003 | CN1442159A Traditional Chinese medicine for treating cancer and its preparation method |
| 09/17/2003 | CN1442154A Snake venom capsule for treating lymph cancer and its preparation method |
| 09/17/2003 | CN1442139A Medicinal composition for treating inflammation |
| 09/17/2003 | CN1442135A Application of scutellaria root extract in preparation of anti-stomach cancer medicine |
| 09/17/2003 | CN1442134A Application of scutellaria root extract in preparation of anti esophageal cancer medicine |
| 09/17/2003 | CN1121391C Substituted 3-cyano quinolines |
| 09/17/2003 | CN1121389C Cyanoguanidines as cell proliferation inhibitors |
| 09/17/2003 | CN1121380C Anti tumor bis dicarboxylic diamino platinum derivatives and its medicinal composition |
| 09/17/2003 | CN1121376C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives and matrix metalloprotease inhibitors |
| 09/17/2003 | CN1121374C Novel trienoic retinoid compounds and method |
| 09/17/2003 | CN1121237C Health care products for regulating immunological function and delaying senility |
| 09/17/2003 | CN1121224C Pharmaceutical composition comprising compound having anti Xa activity and platelet aggregation antagonist compound |
| 09/17/2003 | CN1121218C Application of calmorex in medicine composition for treating hepatocellular carcinoma |
| 09/17/2003 | CN1121214C Use of alicyclic diamines as immunomodulators |
| 09/16/2003 | US6620937 Intermediates in the synthesis of camptothecin and related compounds and synthesis thereof |
| 09/16/2003 | US6620936 9-aminoacridine derivatives and process for the preparation thereof |
| 09/16/2003 | US6620929 1,3-Dipolar cycloadditions to polypyrrolic macrocycles |
| 09/16/2003 | US6620919 Lipoxin compounds and their use in treating cell proliferative disorders |
| 09/16/2003 | US6620851 Methods for the treatment of neuropathic pain and other disorders using R(−)-ketoprofen |
| 09/16/2003 | US6620843 Compound based on triptolide, 16- hydroxytriptolide or tripdiolide (2-hydroxytriptolide) which is derivatized at the 12,13-epoxy group or at the lactone ring of the parent compound. |
| 09/16/2003 | US6620842 Chalcones |
| 09/16/2003 | US6620840 Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 09/16/2003 | US6620832 Substituted ureas |
| 09/16/2003 | US6620831 Indazoles substituted with 1,1-dioxoisothiazolidine useful as inhibitors of cell proliferation |
| 09/16/2003 | US6620828 Antiproliferative agents |
| 09/16/2003 | US6620820 Inhibitors of bone reabsorption and antagonists of vitronectin receptors |
| 09/16/2003 | US6620816 Method for treating tumors by the administration of tegafur, uracil, folinic acid, and cyclophosphamide |
| 09/16/2003 | US6620806 Estrogen agonist/antagonist to prevente myocardial infarction or stroke, maintaining or improving vascular reactivity, treat renal failure, peripheral arterial occlusive disease, coronary artery disease, or raynaud's phenomenon |
| 09/16/2003 | US6620804 Selenophene anti-tumor agents |
| 09/16/2003 | US6620801 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 09/16/2003 | US6620783 Human SMN-like protein (HSLP) and polynucleotides which identify and encode HSLP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating |
| 09/16/2003 | US6620779 Administering to an individual for tumor treatment a chemotherapeutically effective amount of antitumor agent carboplatin, and erythropoietin a hematocrit elevator which is administered befor or concurrently with antitumor agent |
| 09/16/2003 | US6620778 Cysteine/glycine rich peptides |
| 09/16/2003 | US6620422 Compositions containing a peptide and polylactic-glycolic acid suitable for preparing subcutaneous implants with an extended release period |